Top Markets
Coin of the day
Catalent, Inc. Catalent, Inc.

Catalent, Inc.

CTLT
Classement en actions #1926
Catalent, Inc., operating globally through its various subsidiaries,... Catalent, Inc., operating globally through its various subsidiaries, specializes in the development and production of comprehensive solutions for a wide array of products, including pharmaceutical drugs, protein-based biologics, advanced cell and gene therapies, and consumer health items. The company's operations are strategically divided into four key segments: Biologics; Softgel and Oral Technologies; Oral and Specialty Delivery; and Clinical Supply Services. The Softgel and Oral Technologies division focuses on the formulation, development, and manufacturing of soft capsules. These are utilized in a diverse range of client products, such as prescription medications, over-the-counter drugs, nutritional supplements, unit-dose cosmetics, and medicinal preparations for animal health. Within the Biologics segment, Catalent undertakes the creation of biologic cell lines, develops and manufactures both cell therapy and viral-based gene therapy, and handles the formulation and production of parenteral dose forms, including vials, prefilled syringes, and cartridges. This segment also provides essential analytical development and testing capabilities. The Oral and Specialty Delivery segment offers extensive formulation, development, and manufacturing expertise across various technologies. It provides integrated downstream solutions spanning clinical development and commercial supply. This segment also features a dedicated oral delivery solutions platform, encompassing preclinical screening, formulation, analytical development, and current good manufacturing practices (cGMP) services. Finally, the Clinical Supply Services segment delivers vital support for drug and biologic clinical trials. Its services include manufacturing, specialized packaging, secure storage, efficient distribution, and comprehensive inventory management. This segment also offers "FastChain," a demand-led clinical supply service. Catalent serves a broad client base, including pharmaceutical, biotechnology, and consumer health organizations, alongside companies in other healthcare sectors like animal health and medical devices, and even the cosmetics industry. The company was founded in 2007 and maintains its headquarters in Somerset, New Jersey.
Prix de l'action
$63.48
Dernière synchronisation: 2024-12-17
Capitalisation boursière
$11.52B
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Catalent, Inc. (CTLT)

Catégorie

Nombre d'actions en circulation pour Catalent, Inc. (CTLT)
Nombre d'actions en circulation au September 2024: 182.00M
Selon les derniers rapports financiers et le cours de l'action de Catalent, Inc., le nombre actuel d'actions en circulation est de 182.00M. À la fin de June 2023, l'entreprise avait 181.00M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Catalent, Inc. (CTLT) de 2011 à 2026
Actions en circulation à la fin de chaque année
Année Actions en circulation Changez
2026 (TTM) 182.00M 0.55%
2024 181.00M 0.00%
2023 181.00M 2.84%
2022 176.00M 4.76%
2021 168.00M 12.15%
2020 149.79M 3.85%
2019 144.25M 9.94%
2018 131.20M 4.96%
2017 125.00M 0.16%
2016 124.80M 4.10%
2015 119.89M 2.20%
2014 117.30M -0.02%
2013 117.32M 0.00%
2012 117.32M 0.00%
2011 117.32M 0.00%
Actions en circulation pour des entreprises similaires ou concurrentes